Opendata, web and dolomites

DUBs26S SIGNED

Role of a novel proteasome-associated DUB – A boon for therapeutics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DUBs26S project word cloud

Explore the words cloud of the DUBs26S project. It provides you a very rough idea of what is the project "DUBs26S" about.

goals    composition    clearing    enzyme    competencies    fact    association    human    fruition    reciprocal    l5    purified    proteins    fixed    strategies    deubiquitinating    multisubunit    expanded    conserved    clinically    enzymes    unravel    live    structure    life    proposing    shatters    tissue    ubiquitin    myriad    preparation    notion    dubs    specificity    applicative    redundant    26s    site    subset    job    embark    independent    search    drug    host    clinical    efforts    embellished    action    basic    active    respective    incorporation    cells    substrate    msc    spheres    dub    ensures    disposal    phyla    extraordinarily    usp14    proposes    enzymatic    span    committed    cancers    experimental    relationship    replacing    instigate    career    reported    relevance    crux    static    largely    drugable    proteasome    interaction    found    usp9x    realign    complexes    eukaryotic    healthy    msca    neurodegeneration    alter    subunit    tools    processivity    training    uch    networking    opens    researcher    tweaks    fits    investigation    labs   

Project "DUBs26S" data sheet

The following table provides information about the project.

Coordinator
TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY 

Organization address
address: SENATE BUILDING TECHNION CITY
city: HAIFA
postcode: 32000
website: www.technion.ac.il

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 182˙509 €
 EC max contribution 182˙509 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-11-01   to  2019-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY IL (HAIFA) coordinator 182˙509.00

Map

 Project objective

Clearing-up old or redundant proteins is essential for cells to live; this job is largely done by 26S Proteasome. The multisubunit complex – 26S Proteasome – is extraordinarily conserved throughout all eukaryotic phyla, in terms of subunit composition and overall structure. However, in preparation of this research proposal, the Researcher found a novel association of 26S proteasome with a clinically important deubiquitinating enzyme (DUB), USP9X. In a subset of proteasome purified from human tissue by the Researcher, USP9X was in fact the major DUB replacing commonly reported enzymes (USP14, UCH-L5). This finding shatters the notion of proteasome as a static, fixed, complex, and opens up the search for expanded spheres of interaction. The crux of this MSC-IF action is the reciprocal relationship between 26S proteasome and USP9X. Using myriad experimental tools at his disposal, the Researcher proposes to unravel how this novel association tweaks each of their respective enzymatic properties. Incorporation of USP9X may alter substrate specificity and processivity of proteasome, as well as its own enzymatic properties. Even in the immediate term, this proposal will realign research efforts – both basic and applicative – towards USP9X as the new drugable target in the ubiquitin-proteasome system. This new enzymatic active site on proteasome complexes will instigate investigation into the cause of USP9X in neurodegeneration and various cancers. This MSCA-IF fits current European challenges to increase healthy life span by proposing strategies for drug design against DUBs of clinical relevance. Two host labs are committed to provide the Researcher with the best training and support to bring his research to fruition and embark his independent career. Novel experimental findings embellished with new technical competencies and networking experience ensures the Researcher’s future career goals.

 Publications

year authors and title journal last update
List of publications.
2019 Indrajit Sahu, Sachitanand M Mali, Prasad Sulkshane, Andrey Rozenberg, Cong Xu, Roni Morag, Manisha Priyadarsini Sahoo, Sumeet K Singh, Zhanyu Ding, Yifan Wang, Sharleen Day, Yao Cong, Oded Kleifeld, Ashraf Brik, Michael H Glickman
Signature activities of 20S proteasome include degradation of the ubiquitin-tag with the protein under hypoxia
published pages: , ISSN: , DOI: 10.1101/2019.12.20.883942
BioRxIV 2020-01-29
2019 Zhanyu Ding, Cong Xu, Indrajit Sahu, Yifan Wang, Zhenglin Fu, Min Huang, Catherine C.L. Wong, Michael H. Glickman, Yao Cong
Structural Snapshots of 26S Proteasome Reveal Tetraubiquitin-Induced Conformations
published pages: , ISSN: 1097-2765, DOI: 10.1016/j.molcel.2019.01.018
Molecular Cell 2019-05-15

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DUBS26S" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DUBS26S" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

SSHelectPhagy (2019)

Regulation of Selective autophagy by sulfide through persulfidation of protein targets.

Read More  

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More  

CODer (2020)

The molecular basis and genetic control of local gene co-expression and its impact in human disease

Read More